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In G0 and G1, DNA double strand breaks are repaired by non-
homologous end joining, whereas in S and G2, they are also
repaired by homologous recombination. The human CtIP pro-
tein controls double strand break (DSB) resection, an event that
occurs effectively only in S/G2 and that promotes homologous
recombination but not non-homologous end joining. Here, we
mutate a highly conserved cyclin-dependent kinase (CDK) tar-
get motif in CtIP and reveal that mutating Thr-847 to Ala
impairs resection, whereas mutating it to Glu to mimic consti-
tutive phosphorylation does not.Moreover, we show that unlike
cells expressing wild-type CtIP, cells expressing the Thr-to-Glu
mutant resect DSBs even after CDK inhibition. Finally, we
establish that Thr-847mutations to either Ala orGlu affect DSB
repair efficiency, cause hypersensitivity towardDSB-generating
agents, and affect the frequency andnature of radiation-induced
chromosomal rearrangements. These results suggest that CDK-
mediated control of resection in human cells operates by mech-
anisms similar to those recently established in yeast.
DNA double strand breaks (DSBs)2 are highly cytotoxic
lesions that can lead to mutations, chromosomal aberrations,
or cell death. Defects in DSB signaling and/or repair can cause
pathologies, including neurodegenerative disease and cancer
predisposition. DSBs are repaired by two main mechanisms (1,
2): non-homologous end joining (NHEJ) and homologous
recombination (HR). NHEJ ligates broken DNA ends without
requiring extensive sequence complementarity and assumes
the greatest importance in G0 and G1 (3). By contrast, HR is
generally restricted to S and G2, where it can ensure accurate
repair by using sister chromatid sequences as the repair tem-
plate (4–6). Such cell cycle control of DSB repair is important
because if HR is employed in G1, it can generate gross chromo-
somal rearrangements by using spurious homologous se-
quences as repair templates.
Although variousmechanisms likely control HR, a prime site
of regulation is at the level of 5 to 3 DSB resection. Resection
is needed for HR but not for NHEJ and is governed by CDK
activity in yeast and mammalian cells, occurring effectively in
S/G2 but not G0/G1 (5–7). Recent work has shown that a key
target for this control in yeast is the Sae2 protein, which is
phosphorylated on Ser-267 by CDK to promote resection (8).
Notably, Sae2 counterparts have been identified in other orga-
nisms, including vertebrates (9–12), and with the exception of
Schizosaccharomyces pombe Ctp1 (9), they all share a short
homologous region in their C termini containing a CDK con-
sensus site that aligns with Ser-267 of Sae2 (10–12). We have
recently shown thatmutating Sae2 Ser-267 to Ala to prevent its
phosphorylation impairs resection and consequently reduces
HR, whereas altering Ser-267 to Glu mimics constitutive phos-
phorylation and allows some resection even in the absence of
CDK activity (8). Here, we carry out analogous studies on the
equivalent CDK consensus motif of CtIP and thus provide evi-
dence that CDK-mediated control of DSB resection operates
by conserved mechanisms in Saccharomyces cerevisiae and
humans.
EXPERIMENTAL PROCEDURES
Cell Culture, siRNA Transfection, and Cell Survival—U2OS
cells stably expressing GFP-CtIP variants were grown in Dul-
becco’s modified Eagle’s medium (Sigma-Aldrich) supple-
mented with 10% fetal bovine serum (BioSera), 100 units/ml
penicillin, and 100 g/ml streptomycin (Sigma-Aldrich) sup-
plemented with 0.5 mg/ml G418 (Invitrogen). siRNA duplex
against CtIP (GCUAAAACAGGAACGAAUC; MWG Biotec)
was previously described (11), and siRNA transfections were
performedwith 50 nM final oligonucleotide concentrations and
Oligofectamine (Invitrogen). Experimentswere performed 48h
after transfection. Cell survival assays were performed as
described previously (11).
Immunoblotting—Extracts were prepared in 4% SDS, 20%
glycerol, 120 mM Tris-HCl, pH 6.8, and proteins were resolved
by SDS-PAGE and transferred to nitrocellulose followed by
immunoblotting. R. Baer (Columbia University) provided a
mouse monoclonal CtIP antibody, and X. Yu (University of
MichiganMedical School) provided the phospho-Ser-327 anti-
body. Other antibodies were from AbCam (Mre11, RPA32),
Bethyl Laboratories (RPA32-pS4/S8), Santa Cruz Biotechnol-
ogy (BRCA1, GST), and Roche Applied Science (GFP).
In Vitro CDKAssay—AGST-fused version of the CtIP C-ter-
minal region (residues 790–897) was affinity-purifiedwith glu-
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tathione-Sepharose 4B (Amersham Biosciences), incubated
with recombinant CDK2/cyclin A (Upstate Biotechnology)
in the presence of [-32P]ATP according to the manufactur-
er’s instructions, separated by 10% SDS-PAGE, and trans-
ferred to a nitrocellulose membrane. Proteins were detected
with an anti-GST antibody, and phosphorylation was visual-
ized by autoradiography.
Laser Microirradiation—Generation of localized DNA dam-
age by laser was done as previously (13). Cells were fixed with
4% paraformaldehyde (w/v) in PBS for 15min, treated with 0.2%
Triton X-100 in PBS for 10 min, washed three times with PBS,
and then co-immunostained with antibodies against H2AX
(Cell Signaling Technology), cyclin A (Santa Cruz Biotechnol-
ogy), and RPA32 (Lab Vision Corp.). For detection, Alexa Fluor
594- (red) and 647- (far red) conjugated secondary antibodies
were used (Molecular Probes, Paisley, UK). Samples were visu-
alized with an Olympus inverted confocal laser microscope by
sequential scanning of the emission channels.
Immunofluorescence Microscopy—For RPA focus detection,
U2OS cells expressing GFP-CtIP fusions were transfected with
CtIP siRNA, and 2 days later, they were treated with 1 M
camptothecin or 10 Gy of ionizing radiation (IR) and collected
1 h afterward. Following pre-extraction for 5min on ice (25mM
Hepes, pH 7.4, 50mMNaCl, 1mM EDTA, 3mMMgCl2, 300mM
sucrose, and 0.5% Triton X-100), cells were fixed with 4%
paraformaldehyde (w/v) in PBS for 15 min. Coverslips were
washed three times with PBS and then co-immunostained as
above.
Random Plasmid Integration—Assays were as described pre-
viously with minor modifications (14). One day after transfec-
tion with CtIP siRNA, cells were transfected with PvuI-linear-
ized pCDNA4-HISMAX-LacZ (Invitrogen). The following day,
cells were collected, counted, and plated on three plates, one
containing 1 mg/ml Zeocin. One day after plating, cells on a
plate lacking Zeocin were assessed for transfection efficiency
by a -galactosidase staining kit (Invitrogen), and the other
two plates were incubated for 10–14 days at 37 °C for colony
formation. Colonies were stained with 0.5% crystal violet,
20% ethanol and counted. Integration events (number of col-
onies on plates containing Zeocin) were normalized to trans-
fection (number of -galactosidase-positive cells) and plat-
ing efficiencies (colonies after 14 days of growth without
Zeocin).
Chromosomal Analyses—Following CtIP depletion, cells
were exposed to 2 Gy of IR and then allowed to recover at 37 °C
for 8 h in fresh medium before chromosome preparation.
Within these 8 h, cells were treated with caffeine (2 mM final
concentration) for the last 5 h to allow cells with gross chromo-
somal rearrangements (GCRs) to overcome the G2/M check-
point and enter mitosis, and for the last 3 h, they were treated
with Colcemid (KaryoMAX, Invitrogen; final concentration 0.1
mg/ml) to induce chromosome condensation. Cells were then
harvested and treated with 0.075 M KCl for 10 min at 37 °C,
fixed in methanol/acetic acid (3/1), washed twice with metha-
nol/acetic acid (3/1), and then spread on a glass microscope
slide, air-dried, and 4,6-diamidino-2-phenylindole-stained.
RESULTS
CtIP Function Is Impaired by Mutating Thr-847—A similar
CDK consensus sequence to that encompassing Sae2 Ser-267 is
present in nearly all Sae2/CtIP orthologues, with the analogous
residue of human CtIP being Thr-847 (Fig. 1A). To investigate
the potential functions of Thr-847 phosphorylation, we gener-
ated stable U2OS cell clones that expressed siRNA-resistant
wild-type GFP-tagged CtIP, or siRNA-resistant CtIP deriva-
tives in which Thr-847 was changed to an unphosphorylatable
Ala (GFP-CtIP-T847A) or to a negatively charged Glu residue
(GFP-CtIP-T847E) tomimic constitutive phosphorylation.We
selected for clones that expressed the engineered protein at
similar levels to endogenous CtIP (Fig. 1B), and a stable cell line
expressing GFP alone was generated as a negative control. As
shown in Fig. 1B, transfection with the CtIP siRNA oligonu-
cleotide effectively depleted endogenous CtIP but not the
siRNA-resistant GFP-CtIP fusion proteins.
As an approach to detect phosphorylation on CtIP Thr-847,
we made several attempts to generate phospho-specific anti-
sera against this site.Whenwe assessed the resulting antisera by
Western immunoblotting, however, this strategy was under-
mined by the antibodies recognizing additional phosphoryla-
tion sites on CtIP (data not shown). By contrast, when we used
the antibodies in indirect immunofluorescence studies, we
observed that a subpopulation (60%) of cells expressing wild-
type GFP-CtIP exhibited a strongly positive signal, whereas
staining was much weaker in cells expressing the CtIP variant,
GFP-CtIP-T847A (we assume that the remaining, weak signal
observed with the T847A mutant was due to cross-reactivity
with other phosphorylation sites). Consistent with the strongly
positive signal reflecting CDK-mediated modification of CtIP
on Thr-847, this signal was markedly diminished when cells
were pretreated with the CDK inhibitor roscovitine (Fig. 1C).
To further substantiate the idea that CtIP is phosphorylated on
Thr-847 by CDK, we purified bacterially expressed wild-type
andThr-847mutated versions of aC-terminal fragment of CtIP
tagged with GST. Next, we subjected these proteins to in vitro
CDK phosphorylation assays with purified CDK/cyclin A and
radioactive ATP (Fig. 1D). Notably, when the wild-type CtIP
fragment was used, radioactive phosphate was incorporated in
a CDK-dependent manner. By contrast, little or no radioactiv-
ity was incorporated into the CtIP derivative bearing the Thr-
847 Thr-to-Ala mutation (Fig. 1D). Collectively, these findings
thereby provided strong support for CtIPThr-847 indeed being
a CDK target.
To assess the potential functions of CtIP Thr-847 phospho-
rylation, we siRNA-depleted endogenous CtIP from the cell
clones expressing GFP-CtIP variants (Fig. 1B) and then
assessed their survival following acute (1 h) treatments with
various concentrations of camptothecin. In agreementwith our
previous data (8), cells expressing the T847ACtIPmutant were
more sensitive to camptothecin than cells expressing wild-type
CtIP andwere essentially as sensitive as control cells expressing
GFP alone (Fig. 2A). By contrast, cells expressing the T847E
CtIP mutant were not hypersensitive to camptothecin and
were, in fact, more resistant than cells expressing wild-type
CtIP (Fig. 2A). As camptothecin cytotoxicity depends on DNA
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replication, it was possible that the above differences in survival
reflected different cell cycle distributions among the various
cell clones. However, fluorescence-activated cell sorter analy-
ses revealed only minor differences in cell cycle distributions
between the cell lines (supplemental Fig. 1A). Furthermore, all
cell lines exhibited similar levels of camptothecin-induced DSB
formation, as assessed by the appearance of phosphorylated
histone H2AX (H2AX) foci (Fig. 2B, black bars). However,
whenwe analyzed the sameH2AX-positive cells for formation
of RPA-coated ssDNA, significant differences were observed.
RPA foci formed efficiently in cells expressingwild-typeCtIP or
theT847Emutant but not in cells expressing theT847Amutant
FIGURE 1. Functional effects ofmutating Thr-847 of CtIP. A, alignment of the region conserved among Sae2/CtIP orthologues. Arrows show the position of
the conserved CtIP Thr-847 and Sae2 Ser-267. A. thaliana, Arabidopsis thaliana; C. elegans, Caenorhabditis elegans; P. nodorum, Phaeosphaeria nodorum; C. glo-
bosum, Chaetomium globosum; N. crassa, Neurospora crassa; C. neoformans, Cryptococcus neoformans; Y. lipolytica, Yarrowia lipolytica; A. gossypii, Ashbya gos-
sypii. B, expression levels of GFP-CtIP derivatives in stably transfected clones before (left) or after (right) siRNA depletion of endogenous CtIP (siCtIP). C, repre-
sentative confocal microscope images of cells expressing wild-type or T847A CtIP variants after immunostaining with a phospho-specific antibody raised
against phosphorylated Thr-847. Cells were incubated in the presence of the CDK inhibitor roscovitine where indicated. D, a GST-fused wild-type or T847A
mutant CtIP C-terminal fragment (residues 750–897) was affinity-purifiedwith glutathione-Sepharose 4B and then incubatedwith [-32P]ATP in the presence
or absence of recombinant CDK2/cyclin A, separated by 10% SDS-PAGE, and transferred to nitrocellulosemembrane. Proteins were detectedwith an anti-GST
antibody (bottom), and phosphorylation was visualized by autoradiography (CDK assay; top).
FIGURE 2. Effects of CtIPmutations on cellular responses to camptothecin-inducedDNAdamage. A, cell survival after exposing cells expressing GFP-CtIP
fusions to the indicated doses of camptothecin; averages and standard deviations (error bars) of three independent experiments are shown. B, quantification
ofH2AXandRPA foci-positive cells andH2AX focus-positive cells for the indicatedCtIP variants after 1 hof treatmentwith 1Mcamptothecin. Averages and
standard deviations (error bars) of four independent experiments are shown. At least 200 cells were counted per experiment.
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or GFP alone (Fig. 2B, white bars). These results indicated that
the ability of CtIP to promote camptothecin resistance is
impaired when Thr-847 is mutated to an unphosphorylatable
Ala residue but not when it is altered to a phospho-mimicking
Glu residue. Furthermore, the camptothecin sensitivity pheno-
type imparted by the CtIP T847A mutation might reflect
impaired processing of camptothecin-induced DSBs into
ssDNA.
CtIP Mutations Affect Recruitment of CtIP and RPA to DNA
Damage—CtIP modulates responses to DNA damage in a cell
cycle-dependent manner and is only effectively recruited to
sites of laser-induced damage in cyclin A-positive cells (S and
G2 cells), when RPA tracts are also formed (11). As CtIP deple-
tion impairs ssDNA formation after camptothecin treatment,
this suggests that assessment of camptothecin-induced RPA
focus formation would be an effective way to test the effects of
mutating CtIP Thr-847. However, this approach has several
limitations. First, camptothecin primarily yields DSBs only in
S-phase; second, CtIP recruitment into discernible foci is diffi-
cult to observe after camptothecin treatment (11); and third, to
observe RPA recruitment to sites of DNA damage, cellular pre-
extraction is required, which impedes co-staining for soluble
cell cyclemarkers such as cyclins. To overcome these problems,
we used laserDNA-damagingmicroirradiation. Thus, we laser-
irradiated the previously described cell clones stably expressing
wild-type or mutated CtIP derivatives after they had been
siRNA-depleted of endogenous CtIP. Next, we assessed the
appearance of DNA damage tracts by immunofluorescence
with antibodies against RPA (to detect RPA-coated ssDNA),
H2AX (to detect damaged chromatin), and cyclin A (to distin-
guish G1 cells from S/G2 cells. Due to limitations in the number
of channels available in the microscope and in the number of
non-cross-reacting secondary antibodies, H2AX and cyclin A
were analyzed in the same channel). As shown in Fig. 3, A–D,
laser-induced H2AX tracts were clearly evident in all irradi-
ated cells, irrespective of whether or not they displayed pan-
nuclear cyclin A staining. By contrast, and as reported previ-
ously (11), wild-type GFP-CtIP was recruited to damage sites in
all S/G2 cells that stained positive for cyclin A (Fig. 3E, filled
arrows) but not in cyclin A-negative G1 cells (open arrows).
Notably, although a similar recruitment kinetics was observed
for the CtIP-T847Amutant (supplemental Fig. 2), RPA recruit-
ment was readily observed in S/G2 cells expressing wild-type
CtIP but not in S/G2 cells expressing CtIP-T847A (Fig. 3, I and
J), implying that Thr-847 phospho-
rylation regulates the ability of CtIP
to promote resection. In line with
this, whereas CtIP-T847Ewas effec-
tively recruited to damage sites in
S/G2 (Fig. 3G, filled arrows; supple-
mental Fig. 2 for kinetics), it was also
recruited to some degree in G1 cells
(more than 80% of G1 cells showed
weak but visible GFP lines; open
arrows). This suggests that mimick-
ing constitutive phosphorylation
enhances CtIP activity and raises
the possibility that this might allow
some CtIP function even in G1 cells. Indeed, cells expressing
CtIP-T847E generally displayed more pronounced RPA
recruitment than cells expressingwild-typeCtIP (Fig. 3,K and I,
respectively), and furthermore, weak RPA recruitment was evi-
dent in more than 90% of G1 cells expressing CtIP-T847E (Fig.
3K, open arrows), although this was less pronounced than in
S/G2 cells (filled arrows). These findings thus suggest that CtIP
Thr-847 controls resection during the cell cycle but imply that
other CDK-mediated phosphorylations are also needed for
optimal resection to occur.
CtIP-T847E Promotes Resection Even Following CDK
Inhibition—Although the above data suggest that mimicking
constitutive phosphorylation of CtIP Thr-847 can partially
overcome the CDK requirement for DNA DSB processing, it
was formally possible that the cyclin A-negative CtIP-T847E
cells displaying RPA recruitment in Fig. 3 were in early S-phase,
whenCDKwas already active, but cyclin A levels were tooweak
for detection. To address this possibility, we siRNA-depleted
endogenous CtIP from cells stably expressing siRNA-resistant
GFP-CtIP variants and then treated them with DMSO (nega-
tive control) or with the CDK inhibitor, roscovitine. (Supple-
mental Fig. 1B shows that the fluorescence-activated cell sorter
distributions of DMSO- and roscovitine-treated samples were
similar, presumably reflecting inhibition of cell cycle transi-
tions by roscovitine.) Next, we treated the cells with X-rays.We
chose x-ray treatment because it generates DSBs in all cell cycle
phases and allowed us to damage a larger number of cells than
we could with laser microirradiation. Subsequently, we
assessed cells for DSB formation (H2AX foci) and ssDNApro-
duction (RPA foci). In line with our previous results, DMSO-
treated cells expressing wild-type GFP-CtIP or GFP-CtIP-
T847E effectively formed RPA foci, whereas cells expressing
GFP-CtIP T847A orGFP alone did not (Fig. 4A). Similar results
were obtained when we detected ssDNA with an anti-bro-
modeoxyuridine antibody labeling method (supplemental Fig.
3), indicating that CtIP Thr-847 indeed controls ssDNA forma-
tion. Taken together with our other data, these findings there-
fore indicate that CtIP phosphorylation on Thr-847 controls
ssDNA formation and RPA recruitment to sites of damaged
DNA induced by camptothecin, laser microirradiation, or
X-rays. Furthermore, we found that although roscovitine
severely curtailed RPA focus formation following exposure to
IR in cells expressing wild-type CtIP, it did not prevent RPA
focus formation in cells expressing CtIP-T847E (Fig. 4A). Nev-
FIGURE 3. Effects of CtIP mutations on recruitment of proteins to laser-induced damage. Representative
images of cells expressing GFP-CtIP variants after laser damage are shown. Cells were immunostained for RPA
(magenta) andH2AXplus cyclinA (red). Damaged cells not expressing cyclinA (G1) and cells positive for cyclin
A (S/G2) are marked with empty and filled arrows, respectively.
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ertheless, careful comparisons revealed that roscovitine treat-
ment did reduce the intensity and number of RPA foci in cells
expressing CtIP-T847E (Fig. 4, B andC), showing that although
CtIP-T847E permits resection even after CDK inhibition, this
resection is less extensive than in the presence of CDK activity.
Although the study of focus formation bymicroscopy is used
commonly in the DNA damage-response field, it has some lim-
itations. On the one hand, foci are complex structures in which
several types of damage can coexist and, therefore, different
DNA repair pathways can operate at the same locations. In
addition, to be visible, the foci must contain thousands of pro-
tein molecules, meaning that more subtle events close to the
DNA lesions might be missed. To complement our data with
focus formation, we therefore prepared extracts from DNA-
damaged or control cells and then analyzed them by Western
immunoblotting for phosphorylation on Ser-4 and Ser-8 of the
32-kDa subunit of RPA (RPA32). These modifications are gen-
erated after different types of DNA damage (15, 16) by mecha-
nisms that involve the DNA-dependent protein kinase
(DNA-PK (17)). Although the precise roles for these RPA32
phosphorylations are not known, because they affect the affin-
ity of RPA toward both ssDNA and double-stranded DNA (18)
and increase the interaction of RPA with the recombination
proteins Rad51 and Rad52 (19), it has been proposed that RPA
Ser-4/8 phosphorylation facilitates RPA eviction and homolo-
gous recombination. Importantly,
as RPA Ser-4/8 phosphorylation
appears to only occur after DNA
resection (11, 17), the detection of
this modified form of RPA is a very
sensitive readout of DNA end proc-
essing. Notably, we readily detected
RPA32 Ser-4/8 phosphorylation,
both by using phospho-specific
antisera and by reduced mobility of
the protein on SDS-PAGE, in irradi-
ated cells expressing wild-type CtIP
or CtIP-T847E but not in cells
expressing GFP alone or GFP-CtIP
T847A (Fig. 4D). Furthermore, we
found that RPA32 Ser-4/8 phospho-
rylation was slightly higher in cells
expressing CtIP-T847E than in cells
expressing wild-type CtIP (Fig. 4D,
left panels). Moreover, although
roscovitine abolished RPA Ser-4/8
phosphorylation in cells expressing
wild-type CtIP, residual RPA phos-
phorylation was still evident after
roscovitine treatment of cells
expressing CtIP-T847E (Fig. 4D,
right panels). These data therefore
provide strong support for CtIP
Thr-847 phosphorylation playing a
key role in mediating cell cycle con-
trol of DSB resection and RPA
recruitment.
Mutation of CtIP Thr-847 Influ-
ences Genome Stability—Controlling DSB resection is thought
to help ensure that the most appropriate DSB repair pathway is
used at each cell cycle stage. In budding yeast, we have shown
that this control depends on Sae2 Ser-267 phosphorylation by
CDK and that defects in this mechanism lead to imbalances
between NHEJ and HR, with the Sae2-S267A mutant favoring
the former and Sae2-S267E the latter (8). Consequently,
although Sae2-S267E mutant cells can repair S-phase-induced
DSBs (such as are generated by camptothecin) that are mainly
repaired by HR, they are mildly hypersensitive to IR due to
deregulated ssDNA formation that appears to impair NHEJ in
G1. To determine whether a similar phenomenon occurs in
human cells, we siRNA-depleted endogenous CtIP from cells
stably expressing siRNA-resistant wild-type or Thr-847
mutated GFP-CtIP derivatives and then assessed cell survival
after IR. Strikingly, and in contrast to the survival data after
camptothecin exposure (Fig. 2A), both CtIP T847A and CtIP-
T847E mutant cells were mildly hypersensitive to IR, similar to
cells lackingCtIP (Fig. 5A). To test the idea that hypersensitivity
of CtIP-T847E cells might reflect impaired NHEJ, we assessed
the ability of these and the other cells to randomly integrate
plasmid DNA into their genome, a process that is mediated by
NHEJ (14, 20). As shown in Fig. 5B, CtIP-T847E cells but not
CtIP T847A orCtIP-depleted cells weremildly but significantly
defective in this process, thus suggesting that the IR hypersen-
γ
FIGURE4.CtIPmutationsaffectDSBprocessing.A, cells expressingCtIP variantswere treatedwithDMSO ()
or 25M roscovitine (Rosc.) () and then irradiated with 10 Gy of IR. One h later, cells were immunostained for
RPA or H2AX. Averages and standard deviations (error bars) of three independent experiments are shown. At
least 200 cellswere countedper experiment.B, representative imagesof cells treated inA.C, thenumberof RPA
foci per cell in cells expressing the GFP-CtIP-T847E mutant in the presence or absence of the CDK inhibitor
roscovitine. Error bars, standard deviations.D, an immunoblot of protein extracts, collected 1 h after irradiation
(10 Gy), of cells expressing the indicated GFP-CtIP fusions. Panels to the left and right contain samples derived
from cells treated in the absence or presence of roscovitine, respectively.
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sitivity of CtIP-T847E cells at least partly reflected impaired
NHEJ.
As a complementary approach to assess the effects of CtIP
Thr-847 mutations, we examined the cell lines for radiation-
induced GCRs. These studies revealed that 2 Gy of irradiation
increased GCR formation in cells expressing wild-type CtIP,
with around 50% of ensuing mitoses presenting at least one
GCR event (Fig. 5C). Furthermore, somewhat more pro-
nounced increases in GCR formation were observed in cells
depleted of CtIP (GFP control) or expressing the CtIPmutants.
Moreover, especially for cells expressing CtIP-T847A or the
GFP control, there was an increase in the proportion ofmitoses
exhibiting multiple GCR events (Fig. 5C). In addition to deter-
mining overall GCR frequencies in the various cell lines, we also
analyzed the data qualitatively by classifying GCRs into the fol-
lowing categories (Fig. 5D and supplemental Fig. 4): “two-end
fusions” in which both arms of two chromosomes are fused;
“one-end fusions” in which only one chromosomal arm of two
chromosomes is fused (both one-end and two-end fusions
probably result fromNHEJ); “arms of different length” in which
chromosome arms exhibit different lengths, probably due to
insertions, deletions, or non-reciprocal exchanges; “chromatid
breaks” in which one of the chromatids is broken but is held
together by cohesion with its sister chromatid; and “complex
GCRs” in which two or more chromosomes have suffered
reciprocal exchanges, probably through aberrant HR. Strik-
ingly, when compared with cells expressing wild-type CtIP,
those expressing CtIP-T847E displayed an increased preva-
lence of complexGCRs and a reduction of fusions, whichwould
be in agreement with increased aberrant HR and decreased
NHEJ in the CtIP-T847E mutant (Fig. 5D). By contrast, cells
expressing CtIP-T847A displayed the opposite pattern, exhib-
iting decreased complex GCRs and increased fusions, which
would be consistent with increased NHEJ and reduced HR in
this context (this pattern was similar to that of control cells
expressing GFP alone; Fig. 5D). Collectively, these data there-
fore support amodel in which CDK-mediated phosphorylation
of CtIP Thr-847 controls DSB resection and thereby influences
choice between the NHEJ and HR pathways of DSB repair.
DISCUSSION
We have investigated the mechanisms by which human cells
control DNA end resection during the cell cycle. Collectively,
our data provide strong support for a model in which resection
is controlled by CDK-mediated modification of CtIP on Thr-
847 in a manner that is analogous to CDK targeting of a related
consensus site (Ser-267) on the budding yeast CtIP counter-
part, Sae2 (8). In light of these findings and the fact that analo-
gous CDK target sites are found in almost all eukaryotic Sae2/
CtIP counterparts, we speculate that this mode of resection
FIGURE5.Effects ofCtIPmutationsonDNArepair andchromosome integrity.A, the survival ofU2OS cells expressingGFP-CtIP fusions after treatmentwith
IR. Averages and standard deviations (error bars) of three independent experiments are shown. B, the effects of CtIPmutations onNHEJ efficiency asmeasured
by randomplasmid integration. Frequenciesof integrationwerenormalized to thevaluesofwild-typeGFP-CtIP, set as 100%.Averages and standarddeviations
(error bars) of three independent experiments are shown. C, the percentage ofmitoses showing 1, 2, 3, 4, or 5 GCRs in cells expressing GFP-CtIP variants either
untreated (left) or treated with 2 Gy of IR (right). At least 100mitoses were analyzed per experiment. Error bars, standard deviations.D, the percentage of each
GCR type in the cells analyzed in C.
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control represents a widespread mechanism to regulate DSB
repair during the cell cycle.
Modification of CtIP Thr-847Modulates DNAResection dur-
ing the Cell Cycle—Our results reveal that CtIP Thr-847 is
needed for effective ssDNA generation, RPA recruitment, and
RPA phosphorylation in response to camptothecin, laser-in-
duced DNA damage, or ionizing radiation. Furthermore, we
have established that mutating Thr-847 to Glu to mimic con-
stitutive phosphorylation allows some resection in the absence
of CDK activity, although this is not as effective as resection in
S or G2 cells. Although it is possible that the T847E mutation
does not fully mimic phosphorylation on this site, we think that
this is unlikely because in S/G2 cells, the CtIP-T847E mutant
promoted resection at least as well as wild-type CtIP. Instead,
we favor a model (similar that to proposed for yeast Sae2 (Ref.
8)) in which CDK targeting of CtIP Thr-847 contributes to DSB
resection but in which additional CDK targets, on other pro-
teins or on CtIP itself, are needed for optimal resection. In this
regard, we note that CtIP is CDK-phosphorylated on Ser-327 to
promote interactions with BRCA1, a protein implicated in
events occurring at resected DSBs (21). Furthermore, although
we have generated phospho-specific antisera against peptides
containing CtIP Thr-847 and they recognize CtIP only when
CDKs are active, phospho-reactivity on Western blots was not
abolished when CtIP was mutated on Thr-847 or was doubly
mutated on Ser-327 and Thr-847 (data not shown). Although
these results have unfortunately precluded the use of such anti-
bodies to study Thr-847 phosphorylation byWestern blot anal-
yses, they nevertheless point to there being otherCDK-depend-
ent sites on CtIP that might potentially control its function.
Effects of Phosphorylation on CtIP Activity—How phospho-
rylation ofCtIPmodulates resection is still notwell understood.
TheCtIP counterpart in budding yeast, Sae2, has been shown to
be an endonuclease that acts cooperatively with the Mre11-
Rad50-Xrs2 (MRX) complex in vitro (22). Furthermore, com-
bining CtIP with human Mre11 and Rad50 was shown to pro-
duce an endonuclease activity that neither component
exhibited alone, although it is not yet known whether CtIP
stimulatesMre11 or vice versa or both (11). Notably, the in vitro
results for the yeast and human proteins were obtained in the
absence of any known protein phosphorylation events, suggest-
ing that phosphorylation of Sae2/CtIP is not absolutely
required for its observed biochemical functions. Nevertheless,
it is established that both CDK-dependent and checkpoint-de-
pendent phosphorylations are required for activation of Sae2/
CtIP in vivo (8, 21, 23). Although it is not yet clear why there are
these apparent differences between the in vivo and in vitro data,
it is possible that, within the cell, Sae2/MRX and CtIP/MRN
(Mre11-Rad50-Nbs1) operate in amore stringent environment
and/or do so in the presence of inhibitory proteins such that
their resection functions are only exhibited upon activating
phosphorylations. Alternatively, or in addition, it is possible
that these modifications promote interactions with additional
factors thatmight act as positive regulators of DNA resection in
S/G2. In this regard, it is noteworthy that the interaction
between CtIP and BRCA1 is controlled by CDK-mediated
phosphorylation of CtIP Ser-327 and that such an interaction is
required for CtIP recruitment to repair centers (21). Although
this suggests that CDK-mediated Thr-847 phosphorylation
might prime CtIP for further phosphorylation on Ser-327, thus
allowing CtIP recruitment to repair foci, several lines of evi-
dence argue against this. First, CtIP T847A is recruited to sites
of DNA damage with similar kinetics to those of wild-type CtIP
or the T847E mutant (supplemental Fig. 2). Second, we have
found that theT847Amutant is still phosphorylated on Ser-327
and that it is still able to interact with BRCA1 (supplemental
Fig. 5). Notably, we have also found that Thr-847 phosphoryl-
ation does not control the interaction between CtIP and MRN
(supplemental Fig. 5) despite the fact that this interaction
occurs through interactions that involve the CtIP C-terminal
region (11). Hence, we propose that CDK activity is likely to
control CtIP activity in at least twoways: one operating through
Thr-847 that affects CtIP function by a mechanism that also
operates in S. cerevisiae (via Sae2 Ser-267) and a second, higher
eukaryote-specific mechanism that operates through BRCA1
interacting with CtIP phosphorylated on Ser-327. Notably, this
latter mechanism seems to play a crucial role in bringing about
CtIP recruitment to DNA damage sites (21), a mechanism that
does not appear to exist in budding yeast, where it has been
shown that Sae2 is always chromatin-bound and can localize to
sites of DNA damage in both G1 and S/G2 independently of any
factors tested so far (24, 25).
Deregulated DNA End Resection Leads to DNA Damage
Hypersensitivity—Irrespective of the precise mechanisms at
play, what seems clear is that CDK targeting of CtIP/Sae2 is
used to restrict resection in phases of the cell cycle when NHEJ
is favored and activate resection in S and G2, when HR is
employed. Indeed, we have shown that lack of CtIP or an inabil-
ity to activate CtIP by CDK-mediated phosphorylation on Thr-
847 causes hypersensitivity toward DSB-generating agents, at
least partly due to defective HR in S/G2. This is especially rele-
vant when DNADSBs are generated by agents such as campto-
thecin in S-phase, when HR is required for DNA replication
restart. Conversely, our data imply that artificial activation of
CtIP by mimicking constitutive phosphorylation of Thr-847
(which allows some DNA resection in the absence of CDK
activity) can also result in deleterious consequences and DNA
damage hypersensitivity. Therefore, the fine regulation of DNA
resection during the cell cycle appears to be critical to ensure
that the cell uses the DSB repair pathway most appropriate to
its cell cycle status. Notably, we have found that both impaired
resection and constitutive activation of resection (by blocking
or mimicking constitutive phosphorylation of CtIP Thr-847,
respectively) lead to increased sensitivity to DNA-damaging
agents and increased formation of GCRs, although by differing
mechanisms.Thus, althoughhampering resection in S/G2 leads
to increased chromosomal fusions, probably due to increased
NHEJ, hyperactivation of resection results in DSBs being pro-
cessed at inappropriate times. Such aberrantly processed ends
can then engage in futile HR cycles, resulting in complex GCRs
and causing cell mortality, probably by mitotic catastrophe.
It is noteworthy that not only CtIP mutations but also
reduced CtIP levels and CtIP overexpression have been
reported in various cancer cell lines (26–29) and that reduced
CtIP levels lead to tumor formation in mouse models (30).
Although these effects could reflect transcriptional functions
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for CtIP (31), it is tempting to speculate that they arise due to
deregulated DSB resection, thus causing mutations and GCRs
that foster tumor formation. For instance, overexpression of
CtIP, especially in G1 when CtIP levels are normally low, might
hyperactivate the DNA resection machinery, thus causing spu-
rious HR or leading to large deletions at sites of NHEJ. On the
other hand, CtIP-inactivating mutations or CtIP haplo-insuffi-
ciency could resemble what we have observedwith CtIP T847A
mutants, in which GCRs apparently arise due to reduced HR. If
deregulated DSB resection is found in certain cancer cells, this
raises the exciting prospect that such defects could be exploited
by intelligent tailoring of existing DNA-damaging chemother-
apies and/or by using compounds that selectively target specific
DNA repair pathways.
Conserved Mechanisms for Regulating DSB Processing by
CtIP/Sae2 Orthologues—The data we have obtained through
mutating CtIP Thr-847 have a strong resonance with results
derived through analyzing the effects ofmutating the analogous
motif of S. cerevisiae Sae2 (8). It therefore seems that this aspect
of CDK-mediated control of DSB processing and repair has
been highly conserved throughout evolution. As analogous
CDK target sites are present in almost all eukaryotic counter-
parts of Sae2/CtIP (10–12), it is tempting to speculate that sim-
ilar control mechanisms operate in diverse eukaryotes to mod-
ulate DSB repair pathway choice during the cell cycle.
Strikingly, the only Sae2/CtIP homologue known that lacks a
site analogous to Thr-847 of human CtIP is S. pombe Ctp1 (9).
Nevertheless, S. pombe Ctp1 is phosphorylated on other sites
by CDK, and its abundance is strongly regulated during the cell
cycle at the transcriptional level, suggesting that these mecha-
nisms serve to control its activity (9, 32). Contrary to S. cerevi-
siae Sae2, which is constitutively expressed in all phases of the
cell cycle, human CtIP is also regulated at the transcriptional
level, its amounts being highest in S and G2. It is therefore
tempting to speculate that human CtIP combines characteris-
tics exhibited by both S. cerevisiae Sae2 and S. pombeCtp1. Fur-
thermore, it is noteworthy that the functions of CtIP-interact-
ing proteins such as BRCA1, which promotes CtIP recruitment
to sites of DNA damage, and retinoblastoma protein 1 (RB),
which controls the G1/S transition, are also cell cycle-regulated
(28, 33–35). This suggests that multiple layers of regulation
combine to fine-tuneCtIP activity during the cell cycle, perhaps
to provide evenmore stringent control of DSB resection than is
evident in the yeast systems.
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